Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes

Journal of Clinical Microbiology

Volumn 47, Issue 7, 2009, Pages 2170-2174

  Kran, Anne Marte Bakken ^a,b   Jonassen, Tom Øystein ^a,b   Sannes, Mette ^a,b   Jakobsen, Kirsti ^a,b   Lind, Andreas ^a,b   Mæland, Arild ^a,b   Holberg Petersen, Mona ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; VIRUS RNA;

ANTIVIRAL RESISTANCE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PLASMA CELL; PRIORITY JOURNAL; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 67650084388     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00519-09     Document Type: Article

References (23)

1. Albert, J., and E. M. Fenyö. 1990. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J. Clin. Microbiol. 28:1560-1564.
2. Bustin, S. A., and T. Nolan. 2004. Pitfalls of quantitative real-time reversetranscription polymerase chain reaction. Biomol. Tech. 15:155-166.
3. Dickover, R., S. A. Herman, K. Saddiq, D. Wafer, M. Dillon, and Y. J. Bryson. 1998. Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR. J. Clin. Microbiol. 36:1070-1073.
4. Di Mascio, M., M. Markowitz, M. Louie, C. Hogan, A. Hurley, C. Chung, D. D. Ho, and A. S. Perelson. 2003. Viral blip dynamics during highly active antiretroviral therapy. J. Virol. 77:12165-12172.
5. García-Bujalance, S., C. Ladrón de Guevara, J. González-García, J. R. Arribas, F. Zamora, and A. Gutiérrez. 2007. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1. J. Microbiol. Methods 69:384-386.
6. Giordano, M., T. Kelleher, R. J. Colonno, A. Lazzarin, and K. Squires. 2006. The effects of the Roche AMPLICOR HIV-1 MONITOR UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisons. J. Clin. Virol. 35:420-425.
7. Grankvist, O., L. Walther, U. Bredberg-Raden, E. Lyamuya, F. Mhalu, A. Gustafsson, G. Biberfeld, and G. Wadell. 1996. Nested PCR assays with novel primers yield greater sensitivity to Tanzanian HIV-1 samples than a commercial PCR detection kit. J. Virol. Methods 62:131-141.
8. Griffith, B. P., and D. R. Mayo. 2006. Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in plasma preparation tubes (PPT). J. Clin. Virol. 35:197-200.
9. Hammer, S. M., J. J. Eron, Jr., P. Reiss, R. T. Schooley, M. A. Thompson, S. Walmsley, P. Cahn, M. A. Fischl, J. M. Gatell, M. S. Hirsch, D. M. Jacobsen, J. S. Montaner, D. D. Richman, P. G. Yeni, and P. A. Volberding. 2008. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society - USA panel. JAMA 300:555-570.
10. Holodniy, M., D. Margolis, R. Carroll, J. Todd, and L. Mole. 1996. Quantitative relationship between platelet count and plasma virion HIV RNA. AIDS 10:232-233.
11. Holodniy, M., L. Rainen, S. Herman, and B. Yen-Lieberman. 2000. Stability of plasma human immunodeficiency virus load in VACUTAINER PPT plasma preparation tubes during overnight shipment. J. Clin. Microbiol. 38:323-326.
12. Holodniy, M. 2006. HIV-1 load quantitation: a 17-year perspective. J. Infect. Dis. 194(Suppl. 1):S38-S44.
13. Jones, L. E., and A. S. Perelson. 2007. Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 45:483-493.
14. May, M., J. A. Sterne, C. Sabin, D. Costagliola, A. C. Justice, R. Thiébaut, J. Gill, A. Phillips, P. Reiss, R. Hogg, B. Ledergerber, A. D'Arminio Monforte, N. Schmeisser, S. Staszewski, M. Egger, and Antiretroviral Therapy (ART) Cohort Collaboration. 2007. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 21:1185-1197.
15. + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:946-954.
16. Ramratnam, B., J. E. Mittler, L. Zhang, D. Boden, A. Hurley, F. Fang, C. A. Macken, A. S. Perelson, M. Markowitz, and D. D. Ho. 2000. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat. Med. 6:82-85.
17. Rebeiro, P. F., A. Kheshti, S. S. Bebawy, S. E. Stinnette, H. Erdem, Y. W. Tang, T. R. Sterling, S. P. Raffanti, and R. T. D'Aquila. 2008. Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures. Clin. Infect. Dis. 47:1354-1357.
18. Sabino, E. C., N. Gaburo, Jr., J. P. Leite, M. Viecili, and L. G. Rosenfeld. 2004. Platelets may affect detection and quantitation of HIV RNA in plasma samples with low viral loads. J. Acquir. Immune Defic. Syndr. 37:1432-1433.
19. Salimnia, H., E. C. Moore, L. R. Crane, R. D. Macarthur, and M. R. Fairfax. 2005. Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 Monitor (version 1.5) standard and ultrasensitive assays caused by freezing patient plasma in centrifuged Becton-Dickinson Vacutainer brand plasma preparation tubes. J. Clin. Microbiol. 43:4635-4639.
20. Squires, K., A. Lazzarin, J. M. Gatell, W. G. Powderly, V. Pokrovskiy, J. F. Delfraissy, J. Jemsek, A. Rivero, W. Rozenbaum, S. Schrader, M. Sension, A. Vibhagool, A. Thiry, and M. Giordano. 2004. Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV. J. Acquir. Immune Defic. Syndr. 36:1011-1019.
21. Stosor, V., F. J. Palella, Jr., B. Berzins, M. Till, A. Leake, J. S. Chmiel, and R. L. Murphy. 2005. Transient viremia in HIV-infected patients and use of plasma preparation tubes. Clin. Infect. Dis. 41:1671-1674.
22. Tremblay, C. L., F. Giguel, D. P. Merrill, J. T. Wong, E. Rosenberg, S. Kalams, B. D. Walker, R. T. D'Aquila, and M. S. Hirsch. 2000. Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture method. J. Clin. Microbiol. 38:4246-4248.
23. Yerly, S., T. V. Perneger, S. Vora, B. Hirschel, and B. Perrin. 2000. Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection. AIDS 14:2805-2812.